GFM
ONC

GF Fund Management’s BeOne Medicines Ltd ONC Stock Holding History

GF Fund Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Buy
707
+90
+15% +$29.1K ﹤0.01% 281
2025
Q4 		$187K Sell
617
-106
-15% -$34.7K ﹤0.01% 302
2025
Q3 		$246K Sell
723
-412
-36% -$125K ﹤0.01% 269
2025
Q2 		$275K Hold
1,135
– – 0.01% 294
2025
Q1 		$309K Buy
+1,135
New +$265K 0.01% 289

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GF Fund Management's ONC Position: Q1 2026 in Review

GF Fund Management increased its BeOne Medicines Ltd (ONC) stake by 15% in Q1 2026, buying an estimated $29.1K and bringing the position to 707 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

GF Fund Management first reported a position in ONC in Q1 2025 and has held it in 5 quarters since. The position peaked at $309K in Q1 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • GF Fund Management held 707 shares of BeOne Medicines Ltd worth $210K as of Q1 2026.
  • GF Fund Management bought 90 BeOne Medicines Ltd shares in Q1 2026, an estimated $29.1K.
  • BeOne Medicines Ltd made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #281 holding.
  • GF Fund Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 5 quarters since.
  • GF Fund Management's BeOne Medicines Ltd position peaked at $309K in Q1 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.